Live from the NIH registry
Studies recruiting near Salt Lake City right now
Top 25 of 1,137 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Utah, PLLC — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
Precision Genomics Medicine Biobank
Any Disease Condition and Reportedly-healthy Subjects
N/A
Observational 100,000 participants sought
Intermountain Healthcare — Murray, Utah (8.0 mi)
· Sponsor: Intermountain Health Care, Inc.
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
START Mountain Region ( Site 0008) — West Valley City, Utah (7.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — West Valley City, Utah (7.0 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Nurix Therapeutics, Inc.
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
Lifestyle Factors, Overweight and Obesity
N/A
Interventional 70 participants sought
College of Health Research Complex--University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Salt Lake Retina — Salt Lake City, Utah (2.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Intermountain Medical Center — Murray, Utah (8.0 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjögren, Sjogren Disease
Phase 1
Interventional 36 participants sought
Cullinan Investigative Site — Salt Lake City, Utah (2.4 mi)
· Sponsor: Cullinan Therapeutics Inc.
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 220 participants sought
START Mountain — West Valley City, Utah (7.0 mi)
· Sponsor: Circle Pharma
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Knee Cartilage Defects
Phase 3
Interventional 300 participants sought
JBR Clinical Research — Salt Lake City, Utah (2.4 mi)
· Sponsor: Medipost, Inc.
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
Wasatch Clinical Research, LLC — Salt Lake City, Utah (2.4 mi)
· Sponsor: Pfizer
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Primary Children's Hospital — Salt Lake City, Utah (2.4 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Salt Lake City, Utah (2.4 mi)
· Sponsor: AstraZeneca
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
HIV Infections
N/A
Interventional 63,000 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Rectal Cancer, Rectal Tumor
N/A
Interventional 250 participants sought
University of Utah Health — Salt Lake City, Utah (2.4 mi)
· Sponsor: Colospan Ltd.
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 16 — West Valley City, Utah (7.0 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Unresectable, Locally Advanced
Phase 1, Phase 2
Interventional 170 participants sought
START Mountain Region — West Valley City, Utah (7.0 mi)
· Sponsor: Recursion Pharmaceuticals Inc.
Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations
Cataract
N/A
Observational 50 participants sought
The Eye Institute of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: The Eye institute of Utah
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Advanced/Metastatic Solid Tumors, Colorectal Cancer
Phase 1, Phase 2
Interventional 523 participants sought
Utah Cancer Specialists — Salt Lake City, Utah (2.4 mi)
· Sponsor: Merus B.V.
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Salt Lake City, Utah (2.4 mi)
· Sponsor: AstraZeneca